{
    "clinical_study": {
        "@rank": "68824", 
        "acronym": "NEAT O", 
        "arm_group": [
            {
                "arm_group_label": "Erythropoietin", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Normal saline", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Hypoxic-ischemic encephalopathy (HIE), a condition of reduced blood and oxygen flow to a\n      baby's brain near the time of birth, may cause death or neurologic disability. Cooling\n      therapy (hypothermia) provides some protection, but about half of affected infants still\n      have a poor outcome. This clinical trial will determine if the drug erythropoietin, given\n      with hypothermia, is safe to use as a treatment that may further reduce the risk of\n      neurologic deficits after HIE."
        }, 
        "brief_title": "Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEAT O)", 
        "condition": [
            "Hypoxic-ischemic Encephalopathy", 
            "Neonatal Encephalopathy", 
            "Birth Asphyxia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hypoxia-Ischemia, Brain", 
                "Hypoxia, Brain", 
                "Asphyxia", 
                "Asphyxia Neonatorum", 
                "Brain Ischemia", 
                "Hypothermia", 
                "Brain Damage, Chronic", 
                "Delirium", 
                "Encephalitis", 
                "Hepatic Encephalopathy", 
                "Neurotoxicity Syndromes"
            ]
        }, 
        "detailed_description": {
            "textblock": "This phase I/II clinical trial is designed to demonstrate:\n\n        1. The feasibility of recruiting, enrolling and following 50 patients with moderate to\n           severe HIE at 5 sites, while meeting specified recruitment and follow-up target goals.\n\n        2. The safety of high-dose Epo therapy in neonates with HIE with respect to systemic organ\n           function and general growth parameters.\n\n        3. The value of brain MRI/MRS performed at 4-7 days of age as a biomarker of motor\n           function at 12 months of age."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Newborns \u2265 36 weeks gestation, < 23 hours of age at time of consent, must meet all 3\n             Inclusion Criteria to be eligible for the study:\n\n               1. Perinatal depression = at least one of the following: a) Apgar \u22645 at 10 min or\n                  b) required             resuscitation (endotracheal or mask ventilation, or\n                  chest compressions) at 10 min or c) pH < 7.0 or base deficit \u226515 in cord,\n                  arterial, or venous blood obtained at <60 min of age;\n\n               2. Moderate to severe encephalopathy = at least 3 of 6 modified Sarnat criteria\n                  present between 1-6 h of birth: a) reduced level of consciousness; b) decreased\n                  spontaneous activity; c) hypotonia; d) decreased suck; e) decreased Moro reflex;\n                  or f) respiratory distress including periodic breathing or apnea; and\n\n               3. Hypothermia = passive or active cooling begun by 6 hours of age.\n\n        Exclusion Criteria:\n\n          -  Intrauterine growth restriction (BW <1800 g);\n\n          -  Major congenital malformation; suspected genetic syndrome, metabolic disorder or\n             TORCH infection;\n\n          -  Head circumference < 2 SD for gestation;\n\n          -  Infant for whom withdrawal of supportive care is being considered; or\n\n          -  Anticipated inability to collect primary endpoint at 12 months of age."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "24 Hours", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01913340", 
            "org_study_id": "P0055603-01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Erythropoietin", 
                "description": "1000 U/kg/dose IV every 48 hours x 5", 
                "intervention_name": "Erythropoietin", 
                "intervention_type": "Drug", 
                "other_name": "Procrit"
            }, 
            {
                "arm_group_label": "Normal saline", 
                "description": "placebo: 1 cc NS IV every 48 hours x 5", 
                "intervention_name": "Normal saline", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Epoetin Alfa"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "erythropoietin", 
            "therapeutic hypothermia"
        ], 
        "lastchanged_date": "April 11, 2014", 
        "location": [
            {
                "contact": {
                    "email": "MulkeySarah@uams.edu", 
                    "last_name": "Sarah Mulkey, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Little Rock", 
                        "country": "United States", 
                        "state": "Arkansas", 
                        "zip": "72202"
                    }, 
                    "name": "Arkansas Children's Hospital Research Institute"
                }, 
                "investigator": [
                    {
                        "last_name": "Sarah Mulkey, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Vivian Yap, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "wuy@neuropeds.ucsf.edu", 
                    "last_name": "Yvonne W Wu, MD, MPH", 
                    "phone": "415-353-3678"
                }, 
                "contact_backup": {
                    "email": "KnowlesK@peds.ucsf.edu", 
                    "last_name": "Karin Knowles", 
                    "phone": "415-514-8139"
                }, 
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94143"
                    }, 
                    "name": "UCSF"
                }, 
                "investigator": [
                    {
                        "last_name": "Roberta A Ballard, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Yvonne W Wu, MD, MPH", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "tchang@cnmc.org", 
                    "last_name": "Taeun Chang, MD", 
                    "phone": "202-259-0170"
                }, 
                "facility": {
                    "address": {
                        "city": "Washington DC", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20010"
                    }, 
                    "name": "Children's National Medical Center"
                }, 
                "investigator": [
                    {
                        "last_name": "Taeun Chang, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "An Massaro, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mathur_a@kids.wustl.edu", 
                    "last_name": "Amit Mathur, MD", 
                    "phone": "314-454-4031"
                }, 
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63110"
                    }, 
                    "name": "Washington University"
                }, 
                "investigator": [
                    {
                        "last_name": "Amit Mathur, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Robert McKinstry, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mayock@u.washington.edu", 
                    "last_name": "Dennis Mayock, MD", 
                    "phone": "206-543-5257"
                }, 
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98105"
                    }, 
                    "name": "Seattle Children's Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Dennis Mayock, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Sandra Juul, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes Study", 
        "other_outcome": [
            {
                "description": "A 43-item questionnaire developed and standardized to assess the functional domains of self-care, motor function, communication and social cognition in young children", 
                "measure": "Warner Initial Developmental Evaluation of Adaptive and Functional Skills (WIDEA)", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }, 
            {
                "description": "This is a validated and widely used tool for classifying severity of motor impairment.", 
                "measure": "Gross Motor Function Classification Scale (GMFCS)", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }
        ], 
        "overall_contact": {
            "email": "wuy@neuropeds.ucsf.edu", 
            "last_name": "Yvonne W Wu, MD, MPH", 
            "phone": "415-353-3678"
        }, 
        "overall_contact_backup": {
            "email": "KnowlesK@peds.ucsf.edu", 
            "last_name": "Karin Knowles", 
            "phone": "415-514-8139"
        }, 
        "overall_official": {
            "affiliation": "University of California, San Francisco", 
            "last_name": "Yvonne W Wu, MD, MPH", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The investigators will monitor organ function and adverse events until hospital discharge from the neonatal intensive care unit", 
            "measure": "Markers of organ function", 
            "safety_issue": "Yes", 
            "time_frame": "Participants will be followed for the duration of hospital stay, an expected averaged of 2 weeks"
        }, 
        "reference": {
            "PMID": "23008465", 
            "citation": "Wu YW, Bauer LA, Ballard RA, Ferriero DM, Glidden DV, Mayock DE, Chang T, Durand DJ, Song D, Bonifacio SL, Gonzalez FF, Glass HC, Juul SE. Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics. Pediatrics. 2012 Oct;130(4):683-91. doi: 10.1542/peds.2012-0498. Epub 2012 Sep 24."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01913340"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The instrument contains 58 items that are broken down into 4 motor sub-scales: prone, supine, sit and stand. The assessment entails observation only with minimal handling, and is typically completed in 10-20 minutes.", 
            "measure": "Alberta Infant Motor Score (AIMS)", 
            "safety_issue": "Yes", 
            "time_frame": "12 months"
        }, 
        "source": "University of California, San Francisco", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Thrasher Research Fund", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Seattle Children's Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Arkansas Children's Hospital Research Institute", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Washington University School of Medicine", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Children's Research Institute", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Stanford University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Kaiser Santa Clara", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of California, San Francisco", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}